GATA4 and coronary artery disorder: Similarly, the phenotypic spectrum of GATA4 mutations in humans is broad, indicating that genetic background (i.e., modifiers) may influence both the penetrance and expressivity of CHD risk genes in humans (Rajagopal et al. 2007).